Investigation of biomarkers of response to treatment with marizomib in GBM patients

Development of cancer is mainly due to uncontrolled cell growth and the proteasome is a cellular component that regulates this process. Resistance to chemotherapy is the main reason for cancer treatment failure, and therefore,there is a need for development of new and potent drugs. Recent studies have shown that proteasome inhibitors effectively inhibit growth of […]

Read More